Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

The kinetics and reproducibility of 18F-Sodium Fluoride (NaF) PET imaging

Karen Kurdziel, Joanna Shih, Andrea Apolo, Liza Lindenberg, Esther Mena, Yolanda McKinney, Baris Turkbey, William Dahut, Ola Landgren and Peter Choyke
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1250;
Karen Kurdziel
1Molecular Imaging Program/Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Shih
2Medical Oncology Branch, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrea Apolo
3Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liza Lindenberg
1Molecular Imaging Program/Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther Mena
1Molecular Imaging Program/Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yolanda McKinney
1Molecular Imaging Program/Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Baris Turkbey
1Molecular Imaging Program/Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Dahut
3Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ola Landgren
3Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Choyke
1Molecular Imaging Program/Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1250

Objectives Although Sodium Fluoride (18F-NaF) bone scanning has been used for many decades, recent advances in PET-CT camera technology mandate a reappraisal of recommended doses and scanning guidelines. We evaluated the kinetics of 18F-NaF using a current PET-CT scanner to reassess the recommended dose, optimal uptake period and inter-study reproducibility.

Methods In this prospective study, 73 patients underwent multiple sequential PET/CT images after receiving 3-5mCi 18F-NaF IV. Twenty-one of these patients underwent repeat baseline studies (mean interval 5 days) to evaluate reproducibility.

Results Imaging with doses in the range of 3-5mCi 18F-NaF produces excellent scan quality. Estimated Radiation dosimetry made using OLINDA1.0, yield an estimated Effective Dose (ED) of 0.062rem/mCi with the urinary bladder, osteogenic cells and the red marrow receiving the highest doses at 0.300, 0.288 and 0.104 rad/mCi respectively. Visual analysis shows that uptake in both normal and abnormal bone increase with time, however, the rate of increase decreases with time. A semi-automated workflow was created (MIM5.2) to provide objective uptake parameters, including the SUV10mean (mean SUV of all pixels within bone with SUV >10) and the mSUVmean (the average of the SUVmean of all malignant lesions identified by the algorithm). The rate of change between 60 and 120minutes for SUV10mean and mSUVmean is 0.1 %/minute. At 60minutes p.i. critical percent differences of 20.9% for SUV10mean and 33.2% for mSUVmean were achieved. This indicates that SUV changes must be greater than these critical values if they are to be considered “real” during treatment monitoring.

Conclusions 18F-NaF PET/CT images can be obtained with modest radiation exposures and can result in highly reproducible imaging parameters at a 60 minute uptake period. This may enable more quantitative measurement of metastatic bone disease.

Research Support Center for Cancer Research/ NCI Intramural Progra

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 53, Issue supplement 1
May 2012
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The kinetics and reproducibility of 18F-Sodium Fluoride (NaF) PET imaging
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
The kinetics and reproducibility of 18F-Sodium Fluoride (NaF) PET imaging
Karen Kurdziel, Joanna Shih, Andrea Apolo, Liza Lindenberg, Esther Mena, Yolanda McKinney, Baris Turkbey, William Dahut, Ola Landgren, Peter Choyke
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1250;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
The kinetics and reproducibility of 18F-Sodium Fluoride (NaF) PET imaging
Karen Kurdziel, Joanna Shih, Andrea Apolo, Liza Lindenberg, Esther Mena, Yolanda McKinney, Baris Turkbey, William Dahut, Ola Landgren, Peter Choyke
Journal of Nuclear Medicine May 2012, 53 (supplement 1) 1250;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Radiopeptide Therapy using Lu-177 3BP-227 in a Patient with Pancreatic Adenocarcinoma
  • Radiolabeing of Tyr-cNGQGEQc with iodine-131 and its biodistribution and radioherapy in nude mice bearing lung adenocarcinoma
  • Analysis on correlation of Tg with lesions counts ratio of 131I-WBS in DTC patients
Show more Oncology: Basic, Translational & Therapy

MTA I: Technical Advances and Quantification Posters

  • Quantitative Na-18F PET/CT Methodologies for Assessing Osteoblastic Tumor Burden
  • Methodology to aid standardization of PET spatial resolution across sites.
  • Lung cancer imaging with respiratory motion-compensated simultaneous PET/MR
Show more MTA I: Technical Advances and Quantification Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire